GO:1905543 interleukin-15 receptor complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905543 (interleukin-15 receptor complex) is a plasma-membrane protein complex that binds IL-15 and minimally comprises an alpha chain, the shared IL-2/IL-15 beta chain (CD122), and the common gamma chain (CD132).
• The alpha subunit (IL-15RA) is unique to this receptor and confers high-affinity, IL-15-specific binding, while the beta and gamma chains are shared with the IL-2 receptor and other cytokine receptors.
• Assembly of the receptor triggers trans-phosphorylation of JAK1/JAK3 and downstream STAT, PI3K/AKT and MAPK signaling that controls NK and T-cell activation, proliferation and cytotoxicity.
• Structural and mutational studies show that the IL-15/IL-15RA interface is highly sensitive to point mutations, making the complex a tractable target for engineered agonists and antagonists.
• The complex is central to cancer immunotherapy because IL-15 delivered as a receptor-bound complex is more potent and less toxic than soluble IL-15 in preclinical leukemia models.
• CRISPR knockout, point-mutation, knock-in and overexpression cell models are the primary tools for dissecting subunit-specific contributions to receptor assembly and signaling.
Description
The interleukin-15 receptor complex (GO:1905543) is a cell-surface protein assembly that specifically binds the cytokine interleukin-15 (IL-15) and transduces its signals into immune cells. It is defined as a complex that contains, at a minimum, an interleukin, an alpha chain, a beta chain and a gamma chain, with optional additional kinase subunits. The alpha chain (IL-15RA) is unique to this receptor and confers IL-15 selectivity, whereas the beta chain (CD122) is shared with the IL-2 receptor and the common gamma chain (CD132) is shared with multiple interleukin receptors. This shared architecture explains why IL-15 and IL-2 signaling overlap yet remain distinct in kinetics and cellular context. For researchers, GO:1905543 matters because it is the molecular entry point for IL-15 biology in natural killer (NK) cells, CD8+ memory T cells and innate lymphoid cells. The complex is not a static entity: its assembly, surface retention and signaling output are regulated by subunit stoichiometry, glycosylation and receptor-associated kinases. Structural work has shown that the IL-15/IL-15RA interface is a conformational switch that can be engineered for superagonist or antagonist activity. Consequently, the receptor complex is both a fundamental cell-biology object and a validated target in immuno-oncology. This article integrates the QuickGO definition of GO:1905543 with published experimental evidence to describe the composition, assembly, signaling mechanism, disease relevance and CRISPR-based research methods for the interleukin-15 receptor complex.
interleukin-15 receptor complex At A Glance
| GO ID | GO:1905543 |
|---|---|
| GO term | interleukin-15 receptor complex |
| Ontology | cellular_component |
| Synonym | IL-15 receptor complex; IL-15-receptor complex; IL15 receptor complex; IL15-receptor complex; interleukin-15-receptor complex |
| Major function | Binds interleukin-15 (IL-15) and initiates IL-15-dependent signal transduction in immune cells |
| Core subunits | IL-15 (ligand), IL-15RA (alpha chain), CD122/IL-2RB (beta chain), CD132/IL-2RG (common gamma chain) |
| Optional subunits | Receptor-associated kinases such as JAK1 and JAK3 |
| Cellular location | Plasma membrane of NK cells, T cells and other IL-15-responsive cells |
| Related ligands | IL-15; the complex shares beta and gamma chains with the IL-2 receptor |
What Is GO:1905543?
GO:1905543, the interleukin-15 receptor complex, is a cellular_component term describing a protein complex that binds interleukin-15 (IL-15). According to the QuickGO definition, the complex consists of, at a minimum, an interleukin, an alpha chain, a beta chain and a gamma chain, plus optional additional kinase subunits. The alpha chain is unique to this receptor and binds IL-15, while the beta chain is shared with the IL-2 receptor and the common gamma chain is shared with multiple interleukin receptors. Synonyms include IL-15 receptor complex, IL-15-receptor complex, IL15 receptor complex, IL15-receptor complex and interleukin-15-receptor complex.
Why Is interleukin-15 receptor complex Important in Cell Biology?
The interleukin-15 receptor complex is important because it converts a soluble cytokine cue into potent activation of cytotoxic lymphocytes, and its subunit composition determines whether IL-15 acts in a cell-contact-dependent or soluble manner. Because the alpha chain is unique to this receptor, it provides a selectivity handle for therapeutic targeting, while the shared beta and gamma chains explain cross-talk with IL-2 and other cytokines. Dysregulated IL-15 receptor signaling has been implicated in cancer immunosurveillance, autoimmune inflammation and muscle biology, making GO:1905543 a high-value node for both mechanistic and translational research.
• Defines the molecular basis for IL-15-specific signaling in NK cells and CD8+ memory T cells.
• Explains why IL-15 and IL-2 share signaling components yet produce distinct biological outcomes.
• Provides a structural template for engineering IL-15 superagonists and antagonists.
• Underpins cancer immunotherapy strategies that use receptor-bound IL-15 for enhanced potency.
• Links cytokine receptor assembly to skeletal muscle IL-15 localization and protein expression.
• Offers subunit-specific targets (IL-15RA, CD122, CD132) for CRISPR knockout and knock-in studies.
• Serves as a model system for studying shared versus private cytokine receptor chains.
• Connects to autoimmune and inflammatory disease mechanisms through common gamma chain signaling.
Structure and Composition of interleukin-15 receptor complex
The IL-15 ligand and alpha chain (IL-15RA)
In simple terms: IL-15 is the key that fits a special lock called IL-15RA, which only this receptor has.
The interleukin-15 receptor complex is defined by its ability to bind IL-15, and the alpha chain (IL-15RA) is the subunit that confers this specificity. IL-15RA binds IL-15 with high affinity and is unique to this receptor, distinguishing it from the IL-2 receptor. Structural studies of the IL-15/IL-15RA interface have revealed a conformational arrangement that is sensitive to mutation, and naturally occurring or engineered mutations can disrupt complex function. In skeletal muscle cells, IL-15RA regulates IL-15 localization and protein expression, indicating that the alpha chain has cell-type-specific roles beyond simple ligand capture.
The shared beta chain (CD122/IL-2RB)
In simple terms: The beta chain is a shared part used by both the IL-15 and IL-2 receptors.
The beta chain, CD122 (IL-2RB), is shared between the IL-15 receptor complex and the IL-2 receptor. This sharing means that IL-15 and IL-2 can engage overlapping signaling machinery, but the presence of the unique alpha chain directs IL-15 specificity. Receptor-associated protein complex assembly in IL-2- and IL-15-activated T-cell lines has been characterized by proteomics, showing that the beta chain participates in distinct protein complexes depending on the activating cytokine. The beta chain is therefore a central node for signal diversification within GO:1905543.
The common gamma chain (CD132/IL-2RG)
In simple terms: The gamma chain is a common part shared by many interleukin receptors.
The common gamma chain, CD132 (IL-2RG), is shared with multiple interleukin receptors and is a required component of the interleukin-15 receptor complex. Because the gamma chain is used by several cytokine receptors, mutations or perturbations affecting it can have pleiotropic effects on immune signaling. The QuickGO definition explicitly includes the gamma chain as a minimal component, alongside the alpha and beta chains, with optional additional kinase subunits. This shared architecture is a key reason why the IL-15 receptor complex is studied in the context of broader cytokine receptor biology.
Optional kinase subunits and signaling assembly
In simple terms: Kinases are helper enzymes that can attach to the receptor and start the signal.
The QuickGO definition allows for optional additional kinase subunits in the interleukin-15 receptor complex. Receptor-associated protein complex assembly in IL-2- and IL-15-activated T-cell lines has been characterized, revealing that kinases and adaptor proteins are recruited to the receptor in a cytokine-dependent manner. These kinase subunits are essential for propagating signals from the receptor to downstream pathways such as STAT, PI3K/AKT and MAPK. The presence of optional kinase subunits means that the exact composition of GO:1905543 can vary by cell type and activation state.
Conformational switching and engineered mimics
In simple terms: The receptor can change shape, and scientists have designed molecules that mimic or block this shape change.
The IL-15/IL-15RA interface behaves as a conformational switch, and exploiting this switch has enabled the engineering of IL-2 superkines and de novo designed mimics of IL-2 and IL-15. De novo design has produced potent and selective mimics of IL-2 and IL-15, demonstrating that the receptor complex can be engaged by non-natural protein scaffolds. These engineered molecules are valuable tools for probing the structural requirements of GO:1905543 and for developing receptor-selective therapeutics. Mutation-induced dysfunction of the human IL-15/IL-15RA complex further highlights how sensitive the assembly is to structural perturbations.
Key Genes Involved in GO:1905543 interleukin-15 receptor complex
The following genes and proteins are the principal components and regulators of the interleukin-15 receptor complex (GO:1905543), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL15 | Encodes the interleukin-15 ligand that binds the receptor complex | Central to IL-15-dependent immune activation and immunotherapy |
| IL15RA | Encodes the alpha chain unique to the IL-15 receptor complex | Confers IL-15 specificity and regulates IL-15 localization |
| IL2RB | Encodes the beta chain (CD122) shared with the IL-2 receptor | Mediates shared signaling between IL-2 and IL-15 |
| IL2RG | Encodes the common gamma chain (CD132) shared by multiple interleukin receptors | Required component of the receptor complex |
| JAK1 | Kinase subunit associated with the receptor complex | Phosphorylates downstream STAT proteins upon receptor activation |
| JAK3 | Kinase subunit associated with the common gamma chain | Propagates IL-15 receptor signaling in immune cells |
| STAT3 | Transcription factor activated downstream of the receptor complex | Mediates gene expression changes in IL-15-stimulated cells |
| STAT5 | Transcription factor activated downstream of the receptor complex | Drives proliferation and effector programs in NK and T cells |
| PIK3CA | Catalytic subunit of PI3K downstream of the receptor complex | Links receptor activation to AKT signaling |
| AKT1 | Serine/threonine kinase downstream of PI3K | Promotes survival and metabolic reprogramming in IL-15-stimulated cells |
| MAPK1 | Mitogen-activated protein kinase downstream of the receptor complex | Transmits proliferative signals from the receptor |
| MAPK3 | Mitogen-activated protein kinase downstream of the receptor complex | Transmits proliferative signals from the receptor |
| IL2 | Cognate ligand of the shared IL-2 receptor | Provides comparative context for shared beta and gamma chains |
| IL2RA | Alpha chain of the IL-2 receptor | Contrasts with IL-15RA in receptor-specific studies |
| CD8A | Marker of cytotoxic T cells responsive to IL-15 | Used to identify IL-15-responsive T-cell populations |
| NCAM1 | Marker of NK cells responsive to IL-15 | Used to identify IL-15-responsive NK cells |
| FOXP3 | Regulatory T-cell transcription factor | Helps distinguish IL-15 effects on effector versus regulatory T cells |
How Is interleukin-15 receptor complex Regulated?
The interleukin-15 receptor complex is regulated at multiple levels. Subunit expression, particularly of IL-15RA, controls the availability of high-affinity binding sites and influences whether IL-15 acts in a cell-contact-dependent or soluble manner. Receptor-associated protein complex assembly in IL-2- and IL-15-activated T-cell lines is dynamic and cytokine-dependent, indicating that the composition of the complex is remodeled upon activation. Downstream kinase recruitment, including JAK1 and JAK3, is required for signal propagation and is subject to feedback regulation. In skeletal muscle cells, IL-15RA regulates IL-15 localization and protein expression, showing that the receptor complex is also controlled at the level of intracellular trafficking. Structural constraints at the IL-15/IL-15RA interface further regulate complex function, as mutation-induced dysfunction can impair assembly and signaling.
interleukin-15 receptor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL15 | Cancer immunotherapy and immune activation | IL15 knockout or overexpression cell lines |
| IL15RA | Skeletal muscle IL-15 localization and receptor dysfunction | IL15RA point-mutation and knockout models |
| IL2RB | Shared IL-2/IL-15 signaling in immune disorders | IL2RB knockout T-cell lines |
| IL2RG | Common gamma chain-related immune deficiency | IL2RG knockout or knock-in models |
| JAK3 | Kinase-dependent immune signaling defects | JAK3 point-mutation cell models |
Cancer immunotherapy
The interleukin-15 receptor complex is a central mediator of anti-tumor immunity because it activates NK cells and CD8+ memory T cells. In a cancer cell-delivered murine leukemia model, IL-15 presented as a receptor-bound complex was more potent than soluble IL-15, highlighting the therapeutic importance of receptor assembly. Engineered mimics of IL-2 and IL-15 that engage the shared receptor components have been developed as potent and selective immunotherapeutic agents. These findings position GO:1905543 as a key node in immuno-oncology research.
Autoimmune and inflammatory conditions
Because the common gamma chain (CD132) is shared with multiple interleukin receptors, perturbations in the interleukin-15 receptor complex can influence inflammatory signaling beyond IL-15 alone. IL-15 and its receptor complex have been implicated in the persistence of autoreactive lymphocytes, and the shared beta and gamma chains provide points of cross-talk with IL-2 signaling. Understanding the subunit-specific contributions of GO:1905543 is therefore relevant to autoimmune disease research.
Skeletal muscle biology
IL-15RA regulates IL-15 localization and protein expression in skeletal muscle cells, linking the interleukin-15 receptor complex to muscle physiology. This cell-type-specific role indicates that GO:1905543 is not restricted to immune cells and may participate in metabolic and structural functions in muscle. Research into muscle-related IL-15 signaling benefits from understanding the receptor complex composition defined by GO:1905543.
Structural dysfunction and mutation
Mutation-induced dysfunction of the human IL-15/IL-15RA receptor complex demonstrates that single amino acid changes can impair receptor function. Structural studies of the IL-15/IL-15RA interface have revealed conformational switches that are critical for complex activity. These findings have implications for understanding genetic variants that affect IL-15 receptor signaling and for designing receptor-selective therapeutics.
From interleukin-15 receptor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does IL15RA loss abolish IL-15 receptor complex assembly? | IL15RA knockout cell line |
| Which residues in IL-15RA are required for IL-15 binding? | IL15RA point-mutation knock-in |
| Can a tagged IL-15RA report receptor complex localization? | Tagged knock-in of IL15RA |
| Does overexpression of IL-15 enhance receptor-mediated signaling? | IL15 overexpression cell line |
| How does CD122 contribute to shared IL-2/IL-15 signaling? | IL2RB knockout and rescue models |
| What is the effect of common gamma chain mutation on receptor function? | IL2RG point-mutation knock-in |
How to Study the interleukin-15 receptor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Affinity proteomics | Receptor-associated protein complex composition | Identifying subunits and kinases in GO:1905543 |
| Structural biology | Three-dimensional arrangement of IL-15/IL-15RA interface | Understanding conformational switches and mutations |
| Site-directed mutagenesis | Effect of specific residues on receptor function | Mapping mutation-induced dysfunction |
| Flow cytometry | Surface expression of receptor subunits | Assessing IL-15RA, CD122 and CD132 levels |
| Western blotting | Phosphorylation of JAK/STAT and MAPK pathways | Measuring downstream signaling |
| Immunofluorescence | Subcellular localization of IL-15 and IL-15RA | Studying receptor trafficking in muscle cells |
| Cytotoxicity assays | NK and T-cell killing activity | Evaluating receptor-bound IL-15 function |
| Reporter assays | Transcriptional activation downstream of the receptor | Screening for receptor agonists or antagonists |
Proteomic characterization of receptor-associated complexes
Receptor-associated protein complex assembly in IL-2- and IL-15-activated T-cell lines has been characterized using proteomic approaches, which can identify the subunit composition and associated kinases of the interleukin-15 receptor complex. These methods are essential for defining the dynamic components of GO:1905543 beyond the minimal alpha, beta and gamma chains.
Structural and mutational analysis
Structural studies and mutational analysis of the IL-15/IL-15RA interface have revealed conformational switches and mutation-induced dysfunction in the human receptor complex. De novo design of IL-2 and IL-15 mimics further demonstrates how structural knowledge can be translated into engineered receptor-binding proteins. These approaches provide residue-level insight into GO:1905543 assembly and function.
Cell-based signaling assays
Cell-based assays measuring STAT, PI3K/AKT and MAPK activation are used to assess signaling downstream of the interleukin-15 receptor complex. In cancer immunotherapy models, comparing receptor-bound IL-15 with soluble IL-15 provides functional readouts of receptor complex activity. These assays link the molecular composition of GO:1905543 to cellular outcomes.
Imaging and localization studies
Imaging approaches have been used to study IL-15 localization and protein expression in skeletal muscle cells, where IL-15RA regulates these processes. Tagged knock-in models can be used to track the interleukin-15 receptor complex in live cells. Such methods complement biochemical and proteomic characterization of GO:1905543.
How CRISPR Can Be Used to Study GO:1905543 interleukin-15 receptor complex
Knockout
CRISPR knockout of IL15RA, IL2RB or IL2RG can abolish specific subunits of the interleukin-15 receptor complex, allowing researchers to test which components are required for IL-15 binding and signaling. Knockout cell lines are useful for dissecting the minimal requirements of GO:1905543 and for validating subunit-specific functions.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes into IL15RA or other subunits to model mutation-induced dysfunction of the human IL-15/IL-15RA receptor complex. Such models are valuable for studying structural determinants of receptor assembly and for testing engineered mimics.
Knock-in
CRISPR knock-in can be used to add epitope tags or fluorescent reporters to IL15RA, enabling tracking of the interleukin-15 receptor complex in live cells. Tagged knock-in models help determine where and when the receptor complex assembles and how it traffics.
Overexpression
CRISPR-mediated overexpression or lentiviral overexpression of IL15 or IL15RA can enhance receptor complex formation and amplify downstream signaling. Overexpression models are useful for studying the consequences of excess ligand or receptor subunit in cancer immunotherapy contexts.
How EDITGENE Supports interleukin-15 receptor complex Research
Researchers studying interleukin-15 receptor complex-related genes often need to determine whether a candidate gene is causally involved in receptor assembly, ligand binding or downstream signaling. CRISPR-based cell models provide a controlled way to test these hypotheses by removing, mutating, tagging or overexpressing specific components of GO:1905543.
Contact EDITGENE today to design your custom CRISPR model for interleukin-15 receptor complex research.
Frequently Asked Questions About interleukin-15 receptor complex
What is the interleukin-15 receptor complex?
The interleukin-15 receptor complex (GO:1905543) is a protein complex that binds IL-15 and consists of at least an alpha chain, a beta chain and a gamma chain, with optional kinase subunits.
What genes are involved in the interleukin-15 receptor complex?
Key genes include IL15, IL15RA, IL2RB, IL2RG and associated kinases such as JAK1 and JAK3.
What is the GO ID for interleukin-15 receptor complex?
The GO ID is GO:1905543, under the cellular_component ontology.
How does the interleukin-15 receptor complex differ from the IL-2 receptor?
The alpha chain (IL-15RA) is unique to the IL-15 receptor, while the beta chain is shared with the IL-2 receptor and the common gamma chain is shared with multiple interleukin receptors.
Why is the interleukin-15 receptor complex important in cancer immunotherapy?
Receptor-bound IL-15 is more potent than soluble IL-15 in preclinical leukemia models, and engineered IL-15 mimics are being developed as immunotherapeutic agents.
What is the role of IL-15RA in the receptor complex?
IL-15RA is the alpha chain that confers IL-15 specificity and regulates IL-15 localization and protein expression in cells such as skeletal muscle.
Can CRISPR be used to study the interleukin-15 receptor complex?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models can be used to dissect subunit-specific functions of GO:1905543.
What diseases are linked to the interleukin-15 receptor complex?
It has been linked to cancer immunotherapy, autoimmune and inflammatory conditions, and skeletal muscle biology.
What are the synonyms for interleukin-15 receptor complex?
Synonyms include IL-15 receptor complex, IL-15-receptor complex, IL15 receptor complex, IL15-receptor complex and interleukin-15-receptor complex.
How is the interleukin-15 receptor complex regulated?
It is regulated by subunit expression, receptor-associated protein complex assembly, kinase recruitment and structural constraints at the IL-15/IL-15RA interface.
Conclusion
The interleukin-15 receptor complex (GO:1905543) is a multi-subunit cell-surface assembly that binds IL-15 and initiates signaling through shared and unique receptor chains. Its composition, assembly and regulation are central to NK and T-cell biology, cancer immunotherapy and muscle physiology. Structural and mutational studies continue to reveal how the IL-15/IL-15RA interface can be engineered for therapeutic benefit. CRISPR-based cell models provide a robust experimental framework for dissecting the subunit-specific contributions of this receptor complex.
References
- 1. Kennedy MK et al.. 1996. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex.. J Clin Immunol 16(3):134-43 PMID: 8734356
- 2. Yoshida S et al.. 2022. Interleukin-15 receptor subunit alpha regulates interleukin-15 localization and protein expression in skeletal muscle cells.. Exp Physiol 107(3):222-232 PMID: 35100657
- 3. Berger A et al.. 2019. Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model.. J Immunother Cancer 7(1):355 PMID: 31856922
- 4. Silva DA et al.. 2019. De novo design of potent and selective mimics of IL-2 and IL-15.. Nature 565(7738):186-191 PMID: 30626941
- 5. Osinalde N et al.. 2017. Characterization of Receptor-Associated Protein Complex Assembly in Interleukin (IL)-2- and IL-15-Activated T-Cell Lines.. J Proteome Res 16(1):106-121 PMID: 27463037
- 6. Levin AM et al.. 2012. Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'.. Nature 484(7395):529-33 PMID: 22446627
- 7. Fiore PF et al.. 2020. Interleukin-15 and cancer: some solved and many unsolved questions.. J Immunother Cancer 8(2) PMID: 33203664
- 8. Batool Z et al.. 2023. Structural basis for the mutation-induced dysfunction of the human IL-15/IL-15α receptor complex.. Phys Chem Chem Phys 25(4):3020-3030 PMID: 36607223
